Novavax
NVAX
126 hedge funds and large institutions have $141M invested in Novavax in 2017 Q2 according to their latest regulatory filings, with 14 funds opening new positions, 37 increasing their positions, 35 reducing their positions, and 17 closing their positions.
6% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 35
0.34% less ownership
Funds ownership: 2.51% → 2.17% (-0.34%)
2% less call options, than puts
Call options by funds: $920K | Put options by funds: $942K
2% less funds holding
Funds holding: 129 → 126 (-3)
18% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 17
19% less capital invested
Capital invested by funds: $174M → $141M (-$33.1M)
Top Buyers
| 1 |
BBA
Baker Bros. Advisors
New York
|
+$1.96M |
| 2 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
+$1.58M |
| 3 |
BlackRock
New York
|
+$1.49M |
| 4 |
JP Morgan Chase
New York
|
+$1.46M |
| 5 |
Renaissance Technologies
New York
|
+$920K |
Top Sellers
| 1 |
State Street
Boston,
Massachusetts
|
-$7.67M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$4.2M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$4.03M |
| 4 |
Millennium Management
New York
|
-$3.83M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$2.02M |
NVAX Hedge Fund Activity: Q2 2017 in Review
126 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Novavax (NVAX) for Q2 2017, worth a combined $141M — down 19% from $174M a quarter earlier.
Sellers outnumbered buyers: 17 funds closed out of NVAX and 14 opened new positions — a net loss of 3 holders — while 35 trimmed existing stakes and 37 added.
The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $1.96M. The largest seller was State Street, cutting an estimated $7.67M.
- 126 institutional investors held Novavax (NVAX) as of Q2 2017, down from 129 in Q1 2017.
- Funds reported $141M of Novavax stock for Q2 2017, down 19% quarter-over-quarter.
- 14 funds opened new Novavax positions in Q2 2017 and 17 closed out, a net change of -3 holders.
- The largest Novavax buyer in Q2 2017 was Baker Bros. Advisors, an estimated $1.96M added.
- The largest Novavax seller in Q2 2017 was State Street, an estimated $7.67M sold.
Based on aggregated 13F filings for Q2 2017.